The Rheumatology Network gout clinical focus page provides information on the latest gout news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for gout drugs.
October 13, 2022
Supplementation with probiotics was shown to improve hyperuricemia and symptoms of gout, among other inflammatory diseases.
October 08, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending October 8, 2022.
October 05, 2022
“Importantly, several different immunomodulation agents may be effective for increasing treatment response rates and seem well tolerated by patients with uncontrolled gout."
September 19, 2022
Drs Orrin M. Troum and Jeff R. Peterson discuss infusion reactions associated with pegloticase and the impact of immunomodulators when used with pegloticase in gout.
September 19, 2022
Orrin M. Troum, MD, and Jeff R. Peterson, MD, discuss challenges with gout treatment.
September 19, 2022
Orrin M. Troum, MD, discusses methods and results of the MIRROR study in gout.
September 15, 2022
Results were based on the phase 4 MIRROR trial, which analyzed differences in treatment response for concomitant therapy compared with placebo in adults with uncontrolled gout.
September 12, 2022
Orrin M. Troum, MD, discusses the background to the MIRROR study in gout.
September 12, 2022
Orrin M. Troum, MD, and Jeff R. Peterson, MD, discuss burden, treatment landscape, and unmet needs in gout.
September 05, 2022
Rheumatology Network's month in review spotlights the most popular content from the past month.